Effect of Maternal Obesity on Labour Induction in Postdate Pregnancy
NCT ID: NCT02788305
Last Updated: 2017-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
288 participants
OBSERVATIONAL
2016-05-01
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Woman is classified as obese if BMI \>=30.
* Prolonged pregnancy was defined as delivery on or after (41+0 weeks) of gestation.
* First informed consent will be obtained.
* Determination of gestational age
* Proper history taking, general and abdominal examinations will be done then digital examination will be performed to determine bishop score.
* And obstetric U/S scan will be done and by which the following data will be obtained :
* Fetal biometry
* Fetal heart activity
* Presentation
* Localization of the placenta.
* Amount of amniotic fluid.
* Exclude multifetal pregnancy.
* Induction of labor will be done using vaginal misoprostol according to the estimated Bishop score.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non obese
BMI\<30. Misoprostol is given for induction of labour according to Bishop score
Misoprostol
Misoprostol 25 micrograms every 6 hours will be given to obese and non obese groups
obese
BMI\>30. Misoprostol is given for induction of labour according to Bishop score
Misoprostol
Misoprostol 25 micrograms every 6 hours will be given to obese and non obese groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
Misoprostol 25 micrograms every 6 hours will be given to obese and non obese groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Post date \>= 41 weeks.
* Absent onset of labor.
* Patient acceptance to join the study after signing an informed consent.
Exclusion Criteria
* Previous caesarean section(CS).
* Multiple gestation
* Any patient who will refuse to be a part of the study.
* Intra- uterine fetal death (IUFD).
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
heba mahmoud ibrahim marie
lecturer at kaselaini hospitals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heba M Marie, M.D.
Role: PRINCIPAL_INVESTIGATOR
KasrElaini Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr wl aini hospitals
Cairo, Greater Cairo, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Maged AM, El-Semary AM, Marie HM, Belal DS, Hany A, Taymour MA, Omran EF, Elbaradie SMY, Mohamed MAK. Effect of maternal obesity on labor induction in postdate pregnancy. Arch Gynecol Obstet. 2018 Jul;298(1):45-50. doi: 10.1007/s00404-018-4767-8. Epub 2018 Apr 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9898
Identifier Type: -
Identifier Source: org_study_id